Finance

Lists
Q2 2026 earnings
See results
1336:HKG
New China Life Insurance Company Ord Shs H
HK$46.94
-0.38%
(-0.18) 1D
Aug 28, 4:08:31 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1336...
Open
HK$47.48
High
HK$47.78
Low
HK$46.84
Mkt. cap
195.32B
Avg. vol.
0.00
Volume
5.75M
Dividend
6.61%
Quarterly dividend
HK$0.78
Ex-dividend date
Aug 7, 2026
P/E ratio
3.46
52-wk high
HK$65.80
52-wk low
HK$41.46
EPS
HK$13.56
Shares outstanding
1.03B
No. of employees
28K
Open
HK$47.48
High
HK$47.78
Low
HK$46.84
Mkt. cap
195.32B
Avg. vol.
0.00
Volume
5.75M
Dividend
6.61%
Quarterly dividend
HK$0.78
Ex-dividend date
Aug 7, 2026
P/E ratio
3.46
52-wk high
HK$65.80
52-wk low
HK$41.46
EPS
HK$13.56
Shares outstanding
1.03B
No. of employees
28K
Profile
New China Life Insurance Co., Ltd. also known as New China Insurance or Xinhua Baoxian Jituan is a Chinese life insurance company based in Beijing. The Chinese government owns more than half of the shares of the company via sovereign fund Central Huijin, via state-owned enterprise Baosteel Group and a financial service company China Securities Finance. The company is a constituent of the CSI 300 Index, FTSE China A50 Index and Hang Seng China Enterprises Index, and is a former constituent of the SSE 50 Index. The company was ranked 427th in 2016 Fortune Global 500 and 297th in 2016 Forbes Global 2000. Wikipedia
About New China Life Insurance Company Ord Shs H
CEO-
Employees27.7K
FoundedSep 28, 1996
Headquarters-
SectorInsurance
Last report
Aug 26, 2026
Fiscal period
Q2 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
28.00B / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
28.70B
10.42B
15.41B
28.00B
Cost of goods sold
6.08B
7.69B
7.17B
8.63B
Cost of revenue
6.08B
7.69B
7.17B
8.63B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.57B
1.21B
645.00M
-645.00M
Operating expense
395.00M
1.55B
528.00M
846.00M
Total operating expenses
6.48B
9.24B
7.70B
9.47B
Operating income
22.22B
1.18B
7.71B
18.53B
Other non operating income
-6.00M
-86.00M
60.00M
-60.00M
EBT including unusual items
21.83B
2.48B
6.73B
19.89B
EBT excluding unusual items
20.74B
160.00M
6.73B
19.89B
Income tax expense
3.77B
-953.00M
230.00M
3.60B
Effective tax rate
17.28%
-38.51%
3.42%
18.08%
Other operating expenses
-1.05B
221.00M
195.00M
1.51B
Net income
18.06B
3.43B
6.50B
16.29B
Net profit margin
62.93%
32.89%
42.18%
58.19%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-744.00M
-858.00M
-936.00M
-486.00M
Net interest expenses
-744.00M
-858.00M
-936.00M
-486.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
22.47B
1.44B
7.98B
18.79B
Gain or loss from assets sale
-
4.00M
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps